Emerging roles of the renin-angiotensin system in select oral diseases

Yixing Liu1, Zhe Liu1,2

  • 1State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, P.R. China.

Oral Diseases
|September 9, 2024
PubMed
Abstract

Insights

The renin-angiotensin system (RAS) impacts oral health, influencing oral squamous cell carcinoma (OSCC), periodontitis, and taste disorders. Imbalances in RAS signaling can worsen these oral conditions.

Area of Science:

  • Cardiovascular Physiology
  • Oral Biology
  • Pathology

Background:

  • The renin-angiotensin system (RAS) is crucial for cardiovascular and renal regulation.
  • RAS components are present in oral tissues, but their role in oral diseases is not well understood.
  • This review focuses on the RAS's impact on oral squamous cell carcinoma (OSCC), periodontitis, oral submucous fibrosis (OSF), and taste alterations.

Purpose of the Study:

  • To review the current literature on the role of the renin-angiotensin system (RAS) in specific oral diseases.
  • To synthesize the known effects of RAS components and their signaling pathways in OSCC, periodontitis, OSF, and ageusia/dysgeusia.

Main Methods:

  • A comprehensive literature search was conducted using PubMed, Web of Science, and Scopus databases up to July 2024.
  • A narrative review approach was employed to synthesize and summarize the findings from the selected studies.

Main Results:

  • In OSCC, the ACE/Ang II/AT1R axis promotes cancer, while ACE/Ang II/AT2R and ACE2/Ang (1-7)/MasR pathways inhibit it.
  • For periodontitis, ACE/Ang II/AT1R exacerbates inflammation and bone loss, whereas ACE2/Ang (1-7)/MasR offers protection.
  • Angiotensin (1-7) [Ang (1-7)] counteracts Ang II's effects in OSF and modulates taste perception in ageusia/dysgeusia.

Conclusions:

  • The renin-angiotensin system (RAS) cascade significantly influences the pathogenesis of OSCC, periodontitis, OSF, and taste disorders.
  • Dysregulation of the RAS pathway can exacerbate the progression and severity of these oral diseases.

Related Concept Videos

Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
510
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
500
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
606
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
398